Related by context. All words. (Click for frequent words.) 76 renal tumors 75 hamartomas 75 pulmonary metastases 74 pancreatic adenocarcinoma 74 breast carcinomas 74 advanced adenomas 74 colorectal carcinoma 73 epithelial tumors 73 MGUS 73 mucinous 73 metastatic lesions 73 gastric adenocarcinoma 73 tumoral 73 hepatocellular carcinomas 73 adenocarcinomas 73 prostate carcinoma 73 sarcomatoid 73 Papillary 73 osteosarcomas 73 carcinoid 73 hyperplastic 72 papillary carcinoma 72 adenomatous polyps 72 HGPIN 72 histologic subtype 72 unresectable tumors 72 colorectal adenocarcinoma 72 axillary lymph nodes 72 pituitary adenomas 72 prostate cancer CaP 72 invasive carcinomas 72 advanced adenoma 72 precursor lesions 72 Endometrial 72 invasive ductal 72 node metastases 71 endometrioid 71 mesotheliomas 71 metachronous 71 atypical hyperplasia 71 Adenomas 71 lobular carcinoma 71 underwent surgical resection 71 paragangliomas 71 cervical lymph nodes 71 GISTs 71 basal cell nevus syndrome 71 pleomorphic 71 histological subtype 71 Hurthle cell 71 papillary renal cell carcinoma 71 skeletal metastases 71 leiomyomas 71 nutlin 3a 71 ADPKD 71 bronchogenic carcinoma 71 HER2 expression 71 lung carcinomas 71 ductal carcinomas 71 ductal breast cancer 70 K ras mutations 70 urothelial carcinoma 70 malignant prostate 70 ductal cancer 70 papillary 70 nonmelanoma skin cancers 70 HER2 overexpression 70 Squamous 70 cisplatin resistant 70 endometrial hyperplasia 70 pathologic examination 70 lung adenocarcinomas 70 metaplasia 70 intestinal metaplasia 70 cell carcinomas 70 carcinoid tumors 70 nodal metastasis 70 gastric carcinoma 70 locoregional recurrence 70 CIN2 + 70 neoplasias 70 nonmelanoma 70 Leukemias 70 relapsed MM 70 colorectal polyp 70 lymph node metastases 70 GBM tumors 70 urothelial cancer 70 Circulating tumor cells 70 idiopathic PAH 69 leiomyoma 69 adenomatous 69 bladder tumors 69 basal cell carcinoma BCC 69 malignant neoplasm 69 squamous cell lung cancer 69 neuroblastoma tumors 69 seminomas 69 carcinoid tumor 69 pCR 69 Adjuvant chemotherapy 69 histopathologic examination 69 #F FDG 69 bladder carcinoma 69 nonsmall cell lung cancer 69 serous ovarian cancer 69 thyroid nodules 69 metastatic neuroendocrine tumors 69 hamartoma 69 peritoneal carcinomatosis 69 operable breast cancer 69 breast carcinoma 69 neuroendocrine cancers 69 bladder cancers 69 histologically 69 advanced neoplasia 69 pheochromocytoma 69 hepatoma 69 liver metastasis 69 underwent resection 69 epithelioid 69 seminoma 69 interstitial fibrosis 69 colorectal neoplasms 69 benign neoplasms 69 pancreatic prostate 69 pancreatic endocrine 69 lung metastases 69 allogeneic HSCT 69 BRCA1 mutation carriers 69 squamous cell carcinoma SCC 69 T1c 68 invasive carcinoma 68 situ LCIS 68 nonmetastatic 68 histologically proven 68 neoplasms 68 thyroglobulin 68 supratentorial 68 familial pancreatic cancer 68 HER2 positive cancers 68 colorectal adenoma 68 malignant pleural mesothelioma 68 chromophobe 68 sentinel nodes 68 colorectal liver metastases 68 lymphocytosis 68 renal cortical 68 intraoperative complications 68 invasive ductal breast cancer 68 proximal colon 68 bronchoalveolar 68 intestinal polyps 68 FDG PET imaging 68 Immunohistochemical staining 68 CIN3 68 thyroid carcinoma 68 KRAS mutations occur 68 pheochromocytomas 68 atrophic gastritis 68 metastatic lymph nodes 68 malignant lesions 68 pathologic diagnosis 68 ductal adenocarcinoma 68 neoplasm 68 Radical prostatectomy 68 prostate adenocarcinoma 68 invasive lobular 68 SLNB 68 histologically confirmed 68 sCJD 68 submandibular gland 68 choriocarcinoma 68 oesophageal adenocarcinoma 68 malignant polyps 68 uveal melanoma 68 thyroid carcinomas 68 renal cysts 68 Cholangiocarcinoma 68 benign nodules 68 intracranial tumors 68 pilocytic astrocytomas 68 Immunohistochemical analysis 68 biochemical relapse 68 differentiated thyroid 68 benign polyps 68 elevated LDH 68 MGd 68 enteroviral infection 68 pT2 68 varicoceles 68 carcinoembryonic antigen 68 follicular lymphomas 68 HIV HCV coinfected 68 BRAF mutations 68 lymphovascular invasion 68 PNET 68 urine cytology 68 renal pelvis 68 esophagogastric junction 68 pancreatic lung 68 atypical ductal hyperplasia 68 haematopoietic 68 EUS FNA 68 lobular cancer 68 cranial irradiation 68 pulmonary metastasis 68 calculi 68 ovarian carcinoma 68 adenoma 68 myelofibrosis polycythemia vera 68 oligodendrogliomas 68 mammographically 67 MYCN amplification 67 immunohistochemical staining 67 grade gliomas 67 epithelial ovarian 67 cervical carcinoma 67 E. faecalis 67 normal karyotype 67 extracapsular extension 67 meningiomas 67 transfusion syndrome 67 medically inoperable 67 haematopoietic stem cell 67 SUVmax 67 B Cell Lymphoma 67 gastric cancers 67 radioiodine therapy 67 astrocytomas 67 nodal metastases 67 cytologically confirmed 67 glioblastoma tumors 67 malignant nodules 67 AML MDS 67 pleural fluid 67 polypoid 67 extramedullary 67 lung nodules 67 basal cell carcinomas 67 familial ALS 67 lactate dehydrogenase 67 uterine tumors 67 total thyroidectomy 67 bile duct cancers 67 NMIBC 67 mediastinal lymph nodes 67 ASCUS 67 osteoid 67 hormone receptor negative 67 Basal cell 67 esophageal squamous cell carcinoma 67 hematopoietic cancers 67 specific antigen PSA 67 malignant growths 67 neoplastic 67 recurrent glioblastoma multiforme 67 squamous cell cancers 67 Gliomas 67 leukaemias 67 intraductal 67 basal cell cancers 67 lobular breast cancer 67 hepatorenal syndrome 67 Squamous cell 67 leukemias lymphomas 67 Postoperative complications 67 colorectal carcinomas 67 Acute myeloid leukemia 67 lobular carcinomas 67 micrometastases 67 somatic mutations 67 SSc 67 testicular germ cell 67 GIST tumors 67 cutaneous melanoma 67 paraganglioma 67 pT3 67 colonic mucosa 67 micrometastasis 67 chlamydial infection 67 primary hyperparathyroidism 67 T1a 67 Histopathologic examination 67 CD# + [001] 67 microvessel density 67 thyroid nodule 67 hypermethylated 67 MALT lymphoma 67 distant metastasis 67 mononuclear cells 67 histologic findings 67 immunocompetent 67 TIMP 67 malignant lymphomas 67 pancreatic carcinoma 67 cytoreduction 67 HER2 amplification 67 CYT# potent vascular disrupting 67 extrahepatic 67 HbF 67 squamous 67 medulloblastomas 67 BRCA1 mutations 66 neurofibromas 66 gallstone disease 66 radical nephrectomy 66 ductal lobular 66 allogeneic hematopoietic stem cell 66 p# mutations 66 metastatic tumors 66 NSCLC tumors 66 Histologically 66 thyrotropin levels 66 sonographic findings 66 malignant neoplasms 66 oral squamous cell 66 neoadjuvant therapy 66 axillary nodes 66 GSTP1 66 urothelial 66 chemoresistant 66 immunohistochemical analysis 66 grade cervical intraepithelial 66 axillary node 66 malignant lymphoma 66 cellularity 66 thymoma 66 Leydig cells 66 endometrial cancers 66 renal carcinoma 66 baseline LDH 66 breast pancreatic 66 adrenocortical cancer 66 metastatic melanomas 66 B7 H3 66 GBMs 66 malignant fibrous histiocytoma 66 metastatic bladder 66 papillomas 66 gastric corpus 66 distant metastases 66 perioperative complications 66 ALT flares 66 underwent radical prostatectomy 66 gadolinium enhanced 66 postoperative chemotherapy 66 ccRCC 66 ovarian breast 66 cell carcinoma 66 intravenous bisphosphonates 66 Renal cell carcinoma 66 malignant lymphocytes 66 histologic subtypes 66 prostate carcinomas 66 CMV infection 66 carcinoids 66 medullary thyroid cancer 66 LVNC 66 carotid stenosis 66 Legg Calvé Perthes disease 66 PCNSL 66 postoperative morbidity 66 asymptomatic carotid stenosis 66 contralateral breast 66 flutamide 66 prostate cancer PCa 66 ischemic lesions 66 carotid plaque 66 leukemia AML 66 adrenalectomy 66 neuroendocrine tumors 66 metastatic gastric 66 Wilms tumors 66 Cytogenetic 66 adjuvant radiotherapy 66 intracranial hemorrhage ICH 66 elevated ALT 66 lactate dehydrogenase LDH 66 carcinoma HCC 66 clinically detectable 66 JMML 66 Leydig cell 66 TTR gene 66 aminotransferases 66 breast endometrial 66 eosinophil count 66 Carcinomas 66 Glioma 66 familial aggregation 66 troponin T 66 Meningiomas 66 GSTT1 66 schwannomas 66 syngeneic 66 leucopenia 66 invasive ductal carcinoma 66 TGF alpha 66 telomerase inhibition 66 HER2 receptor 66 metastatic lung cancer 66 trophoblast cells 66 pretransplant 66 Histological examination 66 Fas ligand 66 localized prostate 66 haematologic 66 lavage fluid 66 pelvic lymph nodes 66 hypervascular 66 squamous carcinoma 66 germline mutations 66 S. aureus isolates 66 completely resected 66 missense mutations 66 testicular tumors 66 pancreatic islet cell 66 HER2 positive tumors 66 thymectomy 66 neoplastic cells 66 telomere lengths 66 p# mutation 66 microsatellite instability 66 LHRH receptor positive 66 untreated metastatic melanoma 66 neuroblastomas 66 thrombocytopenic 66 aplasia 66 extracolonic findings 66 IPAH 66 mutated K ras 66 hyperoxaluria 66 precancerous polyp 66 CC genotype 66 lymphomas leukemias 66 HNSCC 66 Sjögren syndrome 66 nondiabetic patients 66 systemic amyloidosis 66 operable pancreatic cancer 66 basal cell skin 66 liver metastases 66 cytokeratin 66 Mitomycin C 66 cerebral angiography 66 IDH1 mutation 66 mtDNA mutations 65 HER2 positivity 65 gynecologic malignancy 65 TMPRSS2 ERG fusion 65 Medullary thyroid cancer 65 bone scintigraphy 65 xenograft tumors 65 allogeneic bone marrow 65 cytoreductive surgery 65 varices 65 osteochondromas 65 μmol L 65 myeloproliferative neoplasms 65 noncancerous prostate 65 trophoblasts 65 bronchoalveolar lavage fluid 65 monocytic 65 Rectal cancer 65 Epstein Barr Virus EBV 65 premalignant lesions 65 cytological 65 tissue biopsies 65 VEGF expression 65 cutaneous squamous cell carcinoma 65 ependymomas 65 curative resection 65 ERalpha 65 aminotransferase levels 65 CD# expression [001] 65 Carcinoid tumors 65 myeloproliferative diseases 65 intrahepatic 65 Metastases 65 N. gonorrhoeae 65 Adenocarcinoma 65 myelomas 65 cholangiocarcinoma 65 localized renal 65 vestibular schwannomas 65 FDG uptake 65 macroalbuminuria 65 SGPT 65 malignant ascites 65 stage IIIb IV 65 metastatic colorectal 65 cervical lymph node 65 undergone radical prostatectomy 65 monoinfected patients 65 hyperhomocysteinemia 65 ductal 65 nonproliferative 65 urethral stricture 65 metastatic prostate 65 seropositivity 65 malignant ovarian 65 TGF ß1 65 parathyroid carcinoma 65 oncologic outcomes 65 candidemia 65 endometrial carcinoma 65 untreated celiac disease 65 Thyroid nodules 65 lymphoproliferative disorders 65 Basal Cell 65 mesangial 65 GNAQ 65 bFGF 65 microscopic hematuria 65 lung lesions 65 biochemical abnormalities 65 osteoporotic vertebral compression fractures 65 serum calcium levels 65 gross hematuria 65 colorectal cancer CRC 65 bronchoalveolar lavage 65 chorioamnionitis 65 INCB# [003] 65 Macrophage 65 pathogenic mutations 65 parathyroid 65 serum phosphate 65 Chlamydia pneumoniae 65 precancerous cervical 65 metastatic lesion 65 lymph node involvement 65 BRCA2 mutation carriers 65 lymphoma subtypes 65 thoracoscopic lobectomy 65 NNRTI resistance 65 haematological 65 T1DM 65 inducible nitric oxide synthase 65 Surgical resection 65 ptau 65 PSADT 65 IgA deficiency 65 immunostaining 65 ertapenem 65 nonmalignant 65 ErbB2 positive 65 ovarian tumors 65 parenchyma 65 orchitis 65 PBMCs 65 florbetaben 65 rebleeding 65 neuroendocrine carcinoma 65 atherosclerotic lesions 65 colorectal neoplasia 65 TET2 65 gonococcal infection 65 antiangiogenic therapy 65 microbleeds 65 BCR ABL mutations 65 occult metastases 65 pre cancerous lesion 65 Lymph node 65 medulloblastoma tumors 65 neoplastic lesions 65 metastatic GIST 65 ANCA associated 65 clinico pathological 65 EGF receptors 65 LRP5 65 SSc patients 65 GPC5 65 splenic 65 mucosal inflammation 65 progesterone receptor negative 65 eccrine 65 childhood leukemias 65 colorectal tumors 65 chemoembolization 65 precancerous tumors 65 radiochemotherapy 65 angiosarcoma 65 mesenteric 65 decompensated cirrhosis 65 FluCAM arm 65 lymphocytic 65 graft occlusion 65 Chronic myeloid leukemia CML 65 RRM1 65 malignant cancerous 65 tunica vaginalis 65 onset diabetes mellitus 65 chronic rhinosinusitis 65 neurologic complications 65 Li Fraumeni 65 thyrotropin 65 sentinel lymph nodes 65 alanine aminotransferase ALT 65 papillary thyroid carcinoma 65 hepatic metastases 65 sonographic diagnosis 65 histologic examination 65 HBeAg negative 65 Synovial sarcoma 65 glomerular filtration 65 Candida infection 65 Wegener granulomatosis 65 wedge resection 65 bowel polyps 65 OGG1 65 cisplatin chemotherapy 65 BRAF V#E mutation 65 trans retinoic acid 65 urolithiasis 65 bowel cancers 65 CIN3 + 65 hematopoietic cells 65 ß amyloid 65 mesothelin 65 leukocytosis 65 lymphadenopathy 65 osteoid osteoma 65 myeloperoxidase 65 P. acnes 65 cholelithiasis 65 Chronic lymphocytic leukemia 65 GRNOPC1 contains 65 Renal impairment 65 biliary tree 65 preoperative chemotherapy 65 genitourinary tract 65 mediastinitis 65 metastatic malignant 65 Endometrial cancer 65 PCa 65 sonographically 65 anaplastic 65 breast lesions 65 explants 65 BRAF V#E 65 osteoblastic 65 phosphorylated tau 65 hypoperfusion 64 elevated triglyceride levels 64 liver transplant recipients 64 immunoreactivity 64 Adjuvant therapy 64 teratoma 64 atherogenic dyslipidemia 64 hydronephrosis 64 Heavy menstrual bleeding 64 LHRH agonists 64 MSH2 64 colorectal gastric 64 cGy 64 lymph node enlargement 64 Colon polyps 64 metastases 64 ovarian malignancy 64 serum urate levels 64 complete cytogenetic response 64 alemtuzumab treated 64 precancers 64 KRAS oncogene 64 HER2 amplified 64 tumor xenograft models 64 pancreatic neuroendocrine 64 coronary stenosis 64 microglial activation 64 EGFR mutant 64 HCV infections 64 liposarcoma 64 PhG alpha 1 64 essential thrombocythemia 64 lymphocytic leukemia 64 bioavailable testosterone 64 transgenic rats 64 peripheral blood mononuclear 64 hepatocellular carcinoma 64 lichen planus 64 brivanib 64 pharyngeal cancer 64 serum aminotransferase levels 64 Glioblastoma Multiforme 64 scintigraphic 64 ALK mutations 64 distal colon cancer 64 grade squamous intraepithelial 64 immunoblotting 64 HepG2 cells 64 CLA supplementation 64 Ribavirin causes 64 malignant pleural effusion 64 parotid 64 Glioblastoma Multiforme GBM 64 sarcosine 64 HRCT 64 adrenal cortex 64 colorectal polyps 64 lung nodule 64 varicocele 64 Epstein Barr virus EBV 64 tryptase 64 resected pancreatic cancer 64 pre malignant lesions 64 gastrointestinal stromal tumors GISTs 64 prostate TURP 64 adnexal mass 64 busulfan 64 immunohistochemical 64 NP CRNs 64 H pylori 64 neuritic 64 P selectin 64 hypophosphatemia 64 hypercalciuria 64 lumbar disk herniation 64 fibrin deposition 64 BMS# 64 cystic lesions 64 lymphatic tissue 64 axillary lymph node 64 LV dysfunction 64 desmoplastic 64 hepatocellular carcinoma HCC 64 lymph node metastasis 64 chromosome aberrations 64 noncardiac 64 CP CPPS 64 Asymptomatic 64 demonstrated antitumor activity 64 FDG-PET/CT 64 TRAIL R2 64 diabetes mellitus DM 64 EGFR mutations 64 pituitary adenoma 64 esophageal carcinoma 64 clinicopathologic 64 bacteraemia 64 stratifying patients 64 sleeve lobectomy 64 activated microglia 64 percutaneous biopsy 64 ovarian carcinomas 64 fibroadenomas 64 CLL SLL 64 Gleevec resistant 64 fibroma 64 lipomas 64 KRAS mutations 64 sonographically guided 64 chromosomal rearrangement 64 pilocytic astrocytoma 64 EBUS FNA 64 TNF blocker therapy 64 cardiac troponin T 64 bronchial epithelial cells 64 lung ovary 64 peritoneal fluid 64 HAAH 64 radiosensitive 64 radiographic findings 64 acute leukemias 64 Chronic pancreatitis 64 peritoneal cancer 64 Carcinoma 64 biopsy specimens 64 catheter angiography 64 Histological 64 TT genotype 64 adjuvant radiation 64 recurrent NSCLC 64 nonmelanoma skin cancer 64 underlying vasculopathy 64 malignant tissue 64 PAOD 64 EoE 64 thromboses 64 de novo AML 64 arterial calcification 64 S aureus 64 vWF 64 aminotransferase 64 extracranial 64 visceral metastases 64 pulmonary dysfunction 64 PrPSc 64 chronic periodontitis 64 Hypertrophy 64 pmol L 64 resected tumors 64 clinically insignificant 64 spinal metastases 64 Cystatin C 64 BMPR2 64 infarcts 64 sitosterol 64 PSA nadir 64 p# biomarker 64 Nodules 64 treat benign prostatic 64 surgically resected 64 Neutrophil 64 tumor metastases 64 ovarian endometrial 64 dysglycemia 64 malignant brain 64 cerebrospinal fluid CSF 64 flavopiridol 64 nanomolar 64 premalignant 64 Malignant Melanoma 64 kidney urologic 64 lung metastasis 64 aortic atherosclerosis 64 Radiofrequency ablation 64 micronuclei 64 lobular 64 Waldenstrom macroglobulinemia 64 pancreatectomy 64 CYP#B# 64 protein excretion 64 GSTM1 64 salpingo oophorectomy 64 tonsillar 64 flurpiridaz F 64 BRCA deficient 64 removed laparoscopically 64 testicular cancers 64 myelodysplastic myeloproliferative diseases 64 #.#ng/ml 64 colorectal tumor 64 brain lesions 64 gastric cardia 64 chronic GVHD 64 serotonin synthesis 64 pyelonephritis 64 Histologic 64 AA Amyloidosis 64 carcinomas 64 obstructive coronary artery 64 μg ml 64 artery stenosis 64 hypervascular tumors 64 acute aortic dissection 64 echogenicity 64 chromosomal aberrations 64 promoter methylation 64 systolic dysfunction 64 hemodynamically significant 64 hepatectomy 64 lymphocyte proliferation 64 PSMA ADC 64 TP# mutations 64 HBeAg 64 idiopathic membranous nephropathy 64 #F FDG PET 64 chronic HBV infection 64 bacterial prostatitis 64 Cysts 64 colorectal pancreatic 64 TRAIL R1 64 factor PlGF 64 benign lesions 64 EGFR protein 64 lung pancreatic 64 cervical neoplasia 64 preoperative PSA 64 nucleotide substitutions 64 C. trachomatis 64 submucosal 64 Cathepsin B 64 inhibin B 64 allogeneic transplants 64 CTAP# Capsules 64 FLT3 mutations 64 heavily pretreated 64 sentinel lymph node biopsy 64 nephrogenic 64 serum creatinine levels 64 T2 lesions 64 Doxil ® 64 alkaline phosphatase ALP 64 tumor histology 64 ascites 64 serum PSA 64 Microalbuminuria 64 chromosomal mutations 64 somatostatin receptors 64 myometrium 63 superficial basal cell carcinoma 63 histopathological examination 63 beta catenin protein 63 P. gingivalis 63 superficial bladder cancer 63 Anaplastic 63 uterine cervix 63 cytologic 63 cytogenic 63 Parathyroid Hormone 63 diffuse gastric 63 cholestasis 63 glioma tumors 63 cervical intraepithelial neoplasia 63 endometrial ovarian 63 homodimer 63 LRAT 63 Benign tumors 63 lung esophageal 63 clinicopathological features 63 myocardial necrosis 63 pDC 63 malignant pancreatic 63 bronchoalveolar lavage BAL 63 postoperative pathology 63 deep venous thromboses 63 RAS mutations 63 hyperplastic polyps 63 melanocytic nevi 63 nasopharyngeal carcinoma 63 smoldering myeloma 63 Helicobacter pylori infection 63 NGAL 63 liver histology 63 microdeletions 63 Uterine fibroids 63 epithelial ovarian cancer 63 histopathologic findings 63 Epidermal Growth Factor Receptor 63 karyotypes 63 sclerosing 63 hyperphenylalaninemia HPA due 63 proteoglycan 63 idiopathic pulmonary 63 Computed tomography 63 monoclonal gammopathy 63 CMV disease 63 EpCAM expression 63 circulating EPCs 63 histological diagnosis 63 Fibroblast 63 Hepatocellular Carcinoma HCC 63 glomerular 63 TRAIL induced apoptosis 63 pediatric acute lymphoblastic 63 locoregional 63 atypical hemolytic uremic syndrome 63 leukemia ALL 63 vitamin B# folic acid 63 Intravenous immunoglobulin 63 hepato 63 galiximab 63 serum calcium 63 needle aspiration 63 monogenic 63 prostatic hyperplasia 63 VUR 63 ventricular myocardium 63 biliary strictures 63 azacytidine 63 seminal vesicle 63 oligodendroglioma 63 gastrectomy 63 Myelosuppression 63 Brain metastases 63 kaempferol 63 S. aureus infection 63 angiographically 63 thyrotoxicosis 63 Malignant mesothelioma 63 pseudotumor 63 castrate resistant 63 transrectal ultrasound guided 63 del 5q 63 glutamic acid decarboxylase 63 ALT elevation 63 bacteriuria 63 colon rectal 63 microglial 63 CD#c 63 hormone receptor status 63 osteolytic 63 Immunohistochemistry 63 distal colon 63 severe neutropenia 63 definite stent thrombosis 63 myeloproliferative disorders 63 plasma creatinine 63 Ebstein anomaly 63 lacunar 63 Sezary syndrome 63 miRs 63 occlusive disease 63 N telopeptide 63 nonalcoholic steatohepatitis 63 Trichophyton rubrum 63 redox active 63 moderately emetogenic 63 paricalcitol